niacinamide and isosorbide-5-mononitrate

niacinamide has been researched along with isosorbide-5-mononitrate in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's5 (71.43)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Döring, G1
Wagner, G1
Cadeddu, M; Cherchi, A; Lai, C; Lai, G; Onnis, E; Orani, E; Solinas, R1
Holzmann, S; Kukovetz, WR1
Bueno, O; Zavecz, JH1
Drummer, C; Gerzer, R; Ivanova, K; Schaefer, M1

Reviews

1 review(s) available for niacinamide and isosorbide-5-mononitrate

ArticleYear
Pharmacologic therapy of angina pectoris.
    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1995, Volume: 147, Issue:5

    Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Enoximone; Heparin; Humans; Isosorbide Dinitrate; Niacinamide; Nicorandil; Nitroglycerin; Piperazines; Ranolazine; Vasodilator Agents

1995

Trials

3 trial(s) available for niacinamide and isosorbide-5-mononitrate

ArticleYear
Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 3

    Topics: Adult; Aged; Blood Pressure; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Exercise; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Niacinamide; Nicorandil; Potassium Channels; Vasodilator Agents

1992
Selected issues from an overview on nicorandil: tolerance, duration of action, and long-term efficacy.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 3

    Topics: Administration, Oral; Administration, Sublingual; Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Exercise; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Niacinamide; Nicorandil; Nitroglycerin

1992
[A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate].
    Cardiologia (Rome, Italy), 1991, Volume: 36, Issue:9

    Topics: Aged; Angina Pectoris; Double-Blind Method; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Niacinamide; Nicorandil; Placebos; Vasodilator Agents

1991

Other Studies

3 other study(ies) available for niacinamide and isosorbide-5-mononitrate

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Cyclic GMP in nicorandil-induced vasodilatation and tolerance development.
    Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 8

    Topics: Acetylcysteine; Animals; Cattle; Coronary Vessels; Cyclic GMP; Drug Tolerance; In Vitro Techniques; Isosorbide Dinitrate; Niacinamide; Nicorandil; Nitroglycerin; Vasodilation; Vasodilator Agents

1987
Effects of nitric oxide-containing compounds on increases in cytosolic ionized Ca2+ and on aggregation of human platelets.
    European journal of pharmacology, 1993, Jan-04, Volume: 244, Issue:1

    Topics: Calcium; Cytosol; Female; Humans; Isosorbide Dinitrate; Kinetics; Male; Niacinamide; Nicorandil; Nitric Oxide; Platelet Aggregation; Sydnones

1993